Anti-Human CD140a Recombinant Antibody(Tovetumab)
-
产品编号
YR1314
-
别名
科研级 Tovetumab ( 托维妥单抗 ), Anti-CD140a Recombinant Antibody, Research Grade Tovetumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Tovetumab ( 托维妥单抗 ), Anti-CD140a Recombinant Antibody, Research Grade Tovetumab |
| Catalog Number | YR1314 |
| Molecular Name | Tovetumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG2 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Tovetumab is an anti-PDGFRa monoclonal antibody designed for the treatment of cancer. It was developed by MedImmune, and trialed for use in glioblastoma and non-small cell lung cancer. Development was discontinued in 2013. This drug was developed by MedImmune, LLC. |
| CAS Number | 1243266-04-7 |
| Application | IP, IF, FuncS, FCM, Neut, ELISA, ICC |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | CD140a[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
